Trial Profile
A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ozagrel (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 16 Oct 2015 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov
- 10 Jun 2014 New trial record